These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 10097041)
61. Role of the proposed pore-forming segment of the Ca2+ release channel (ryanodine receptor) in ryanodine interaction. Chen SR; Li P; Zhao M; Li X; Zhang L Biophys J; 2002 May; 82(5):2436-47. PubMed ID: 11964232 [TBL] [Abstract][Full Text] [Related]
62. Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis. Tilgen N; Zorzato F; Halliger-Keller B; Muntoni F; Sewry C; Palmucci LM; Schneider C; Hauser E; Lehmann-Horn F; Müller CR; Treves S Hum Mol Genet; 2001 Dec; 10(25):2879-87. PubMed ID: 11741831 [TBL] [Abstract][Full Text] [Related]
63. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95). Ta TA; Pessah IN Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049 [TBL] [Abstract][Full Text] [Related]
64. PharmGKB summary: very important pharmacogene information for RYR1. Alvarellos ML; Krauss RM; Wilke RA; Altman RB; Klein TE Pharmacogenet Genomics; 2016 Mar; 26(3):138-44. PubMed ID: 26709912 [No Abstract] [Full Text] [Related]
65. Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test. Brandt A; Schleithoff L; Jurkat-Rott K; Klingler W; Baur C; Lehmann-Horn F Hum Mol Genet; 1999 Oct; 8(11):2055-62. PubMed ID: 10484775 [TBL] [Abstract][Full Text] [Related]
66. Amino acids 1-1,680 of ryanodine receptor type 1 hold critical determinants of skeletal type for excitation-contraction coupling. Role of divergence domain D2. Perez CF; Mukherjee S; Allen PD J Biol Chem; 2003 Oct; 278(41):39644-52. PubMed ID: 12900411 [TBL] [Abstract][Full Text] [Related]
67. Failure to identify the ryanodine receptor G1021A mutation in a large North American population with malignant hyperthermia. Stewart SL; Rosenberg H; Fletcher JE Clin Genet; 1998 Oct; 54(4):358-61. PubMed ID: 9831351 [TBL] [Abstract][Full Text] [Related]
68. Mutations in RYR1 in malignant hyperthermia and central core disease. Robinson R; Carpenter D; Shaw MA; Halsall J; Hopkins P Hum Mutat; 2006 Oct; 27(10):977-89. PubMed ID: 16917943 [TBL] [Abstract][Full Text] [Related]
69. Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle. Richter M; Schleithoff L; Deufel T; Lehmann-Horn F; Herrmann-Frank A J Biol Chem; 1997 Feb; 272(8):5256-60. PubMed ID: 9030597 [TBL] [Abstract][Full Text] [Related]
70. Ryanodine receptor mutations in malignant hyperthermia and central core disease. McCarthy TV; Quane KA; Lynch PJ Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202 [TBL] [Abstract][Full Text] [Related]
71. The point mutation Arg615-->Cys in the Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia. Otsu K; Nishida K; Kimura Y; Kuzuya T; Hori M; Kamada T; Tada M J Biol Chem; 1994 Apr; 269(13):9413-5. PubMed ID: 7511586 [TBL] [Abstract][Full Text] [Related]
72. RYR1 variant c.38T>G, p.Leu13Arg causes hypersensitivity of the ryanodine receptor-1 and is pathogenic for malignant hyperthermia. van den Bersselaar LR; Greven T; Bulger T; Voermans NC; van Petegem F; Schiemann AH; Parker R; Burling SM; Jungbluth H; Stowell KM; Kamsteeg EJ; Snoeck MMJ Br J Anaesth; 2021 Aug; 127(2):e63-e65. PubMed ID: 34127251 [No Abstract] [Full Text] [Related]
74. [Preliminary report: first identification of known mutation in the ryanodine receptor gene in a Japanese malignant hyperthermia pedigree]. Ichihara Y; Sasaki J; Kikuchi H; Ozawa M; Goto Y; Nonaka I Masui; 2000 Apr; 49(4):404-6. PubMed ID: 10793526 [TBL] [Abstract][Full Text] [Related]
75. Oxidation and reduction of pig skeletal muscle ryanodine receptors. Haarmann CS; Fink RH; Dulhunty AF Biophys J; 1999 Dec; 77(6):3010-22. PubMed ID: 10585923 [TBL] [Abstract][Full Text] [Related]
79. Propofol-induced changes in myoplasmic calcium concentrations in cultured human skeletal muscles from RYR1 mutation carriers. Migita T; Mukaida K; Kawamoto M; Kobayashi M; Nishino I; Yuget O Anaesth Intensive Care; 2007 Dec; 35(6):894-8. PubMed ID: 18084979 [TBL] [Abstract][Full Text] [Related]
80. C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response. Steinfath M; Singh S; Scholz J; Becker K; Lenzen C; Wappler F; Köchling A; Roewer N; Schulte am Esch J J Mol Med (Berl); 1995 Jan; 73(1):35-40. PubMed ID: 7633940 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]